MiR-23a induced the activation of CDC42/PAK1 pathway and cell cycle arrest in human cov434 cells by targeting FGD4

Table 1 The clinical information of PCOS and control groups

Clinical index	PCOS (n = 50)	Control (n = 50)	P
Age	30.98 ± 3.82	30.76 ± 3.12	0.753
E2 (pg/mL)	41.34 ± 12.05	37.65 ± 11.32	0.118
BMI (Kg/m²)	24.48 ± 2.62	22.63 ± 2.48	< 0.001
LH (mIU/mL)	9.35 ± 1.77	7.67 ± 1.80	< 0.001
FSH (mIU/mL)	8.22 ± 1.10	7.79 ± 1.12	0.051
PRL (mIU/L)	270.3 ± 132.5	227.9 ± 116.6	0.091
T (mIU/mL)	1.19 ± 0.53	0.522 ± 0.18	< 0.001
Glu (nmol/mL)	6.33 ± 2.00	5.31 ± 1.89	< 0.05
INS (μU/mL)	21.19 ± 3.79	13.25 ± 5.46	< 0.001

E2 Estradiol, BMI Body Mass Index, LH Luteinizing hormone, FSH Follicule-stimulating hormone, PRL Prolactin, T Testostrone, Glu Glucose, INS Insulin

ISSN: 1757-2215